Innovations

Biomarker predicts resistance to immunotherapies in melanoma

0
Group of the scientists working at the laboratory

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

The best Black Friday pizza oven deals include Ooni, Solo, and more

Previous article

Black and Hispanic men saw worse COVID-19 outcomes, study shows

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations